200064671
Neuronal-Nuclei (NeuN) (Neuronal Marker) Recombinant Mouse Monoclonal Antibody (rNEUN/8054), NeoBiotechnologies™
Mouse Recombinant Monoclonal Antibody
Manufacturer: Fischer Scientific
The price for this product is unavailable. Please request a quote
Antigen
Neuronal-Nuclei (NeuN) (Neuronal Marker)
Concentration
200 μg/mL
Classification
Recombinant Monoclonal
Form
Liquid
Regulatory Status
RUO
Formulation
PBS with 0.5% BSA and 0.5% sodium azide
Gene Alias
D11Bwg0517e; FLJ56884; FLJ58356; fox 1 homolog (C. elegans) 3; fox1 homolog C; Fox-1 homolog C; FOX3; FOX-3; FOX3NeuN; hexaribonucleotide binding protein 3; hexaribonucleotide binding protein 3 (HRNBP3); Hexaribonucleotide-binding protein 3; Hrnbp3; NEUN; NeuN antigen; Neuna60; neuronal nuclear antigen A60; neuronal nuclei; Neuronal nuclei antigen; RBFOX3; RFOX3; RGD1560070; RNA binding fox-1 homolog 3; RNA binding protein; RNA binding protein fox-1 homolog 3; RNA binding protein, fox-1 homolog (C. elegans) 3; RNA binding protein, fox-1 homolog 3
Immunogen
Recombinant fragment (around aa1-200) of human RBFOX3 (NeuN) protein (exact sequence is proprietary)
Primary or Secondary
Primary
Content And Storage
4° C
Gene
RBFOX3
Clone
rNEUN/8054
Applications
Immunohistochemistry (Paraffin)
Conjugate
Unconjugated
Host Species
Mouse
Target Species
Human
Gene Accession No.
A6NFN3
Gene ID (Entrez)
146713
Isotype
IgG1 κ
Purification Method
Protein A/G
Product Type
Antibody
Related Products
Description
- Positive Control:Human brain
- HeLa cells
- Cellular Location: Nucleus
- Cytoplasm
- Neuronal-Nuclei (NeuN) (Neuronal Marker) Recombinant Monoclonal antibody specifically detects Neuronal-Nuclei (NeuN) (Neuronal Marker) in Human samples
- It is validated for Immunohistochemistry (Paraffin)
Compare Similar Items
Show Difference
Antigen: Neuronal-Nuclei (NeuN) (Neuronal Marker)
Concentration: 200 μg/mL
Classification: Recombinant Monoclonal
Form: Liquid
Regulatory Status: RUO
Formulation: PBS with 0.5% BSA and 0.5% sodium azide
Gene Alias: D11Bwg0517e; FLJ56884; FLJ58356; fox 1 homolog (C. elegans) 3; fox1 homolog C; Fox-1 homolog C; FOX3; FOX-3; FOX3NeuN; hexaribonucleotide binding protein 3; hexaribonucleotide binding protein 3 (HRNBP3); Hexaribonucleotide-binding protein 3; Hrnbp3; NEUN; NeuN antigen; Neuna60; neuronal nuclear antigen A60; neuronal nuclei; Neuronal nuclei antigen; RBFOX3; RFOX3; RGD1560070; RNA binding fox-1 homolog 3; RNA binding protein; RNA binding protein fox-1 homolog 3; RNA binding protein, fox-1 homolog (C. elegans) 3; RNA binding protein, fox-1 homolog 3
Immunogen: Recombinant fragment (around aa1-200) of human RBFOX3 (NeuN) protein (exact sequence is proprietary)
Primary or Secondary: Primary
Content And Storage: 4° C
Gene: RBFOX3
Clone: rNEUN/8054
Applications: Immunohistochemistry (Paraffin)
Conjugate: Unconjugated
Host Species: Mouse
Target Species: Human
Gene Accession No.: A6NFN3
Gene ID (Entrez): 146713
Isotype: IgG1 κ
Purification Method: Protein A/G
Product Type: Antibody
Antigen:
Neuronal-Nuclei (NeuN) (Neuronal Marker)
Concentration:
200 μg/mL
Classification:
Recombinant Monoclonal
Form:
Liquid
Regulatory Status:
RUO
Formulation:
PBS with 0.5% BSA and 0.5% sodium azide
Gene Alias:
D11Bwg0517e; FLJ56884; FLJ58356; fox 1 homolog (C. elegans) 3; fox1 homolog C; Fox-1 homolog C; FOX3; FOX-3; FOX3NeuN; hexaribonucleotide binding protein 3; hexaribonucleotide binding protein 3 (HRNBP3); Hexaribonucleotide-binding protein 3; Hrnbp3; NEUN; NeuN antigen; Neuna60; neuronal nuclear antigen A60; neuronal nuclei; Neuronal nuclei antigen; RBFOX3; RFOX3; RGD1560070; RNA binding fox-1 homolog 3; RNA binding protein; RNA binding protein fox-1 homolog 3; RNA binding protein, fox-1 homolog (C. elegans) 3; RNA binding protein, fox-1 homolog 3
Immunogen:
Recombinant fragment (around aa1-200) of human RBFOX3 (NeuN) protein (exact sequence is proprietary)
Primary or Secondary:
Primary
Content And Storage:
4° C
Gene:
RBFOX3
Clone:
rNEUN/8054
Applications:
Immunohistochemistry (Paraffin)
Conjugate:
Unconjugated
Host Species:
Mouse
Target Species:
Human
Gene Accession No.:
A6NFN3
Gene ID (Entrez):
146713
Isotype:
IgG1 κ
Purification Method:
Protein A/G
Product Type:
Antibody
Antigen: P16INK4a
Concentration: 200 μg/mL
Classification: Recombinant Monoclonal
Form: Liquid
Regulatory Status: RUO
Formulation: PBS with 0.5% BSA and 0.5% sodium azide
Gene Alias: Alternative reading frame; Arf; ARF-INK4a; CDK4 inhibitor p16 INK4; CDK4 inhibitor p16-INK4; CDK4I; CDKN2; Cdkn2a; cdkn2a {ECO:0000312; cell cycle inhibitor; cell cycle negative regulator beta; cell cycle regulator; CMM2; Cyclin dependent kinase 4 inhibitor A; cyclin dependent kinase inhibitor 2A; Cyclin dependent kinase inhibitor 2A (p16, inhibits CDK4); cyclin-dependent kinase 4 inhibitor A; Cyclin-dependent kinase inhibitor 2A; cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4); cyclin-dependent kinase inhibitor 2A (p16, inhibits CDK4); cyclin-dependent kinase inhibitor 2a p16Ink4a; cyclin-dependent kinase inhibitor 2a p19Arf; cyclin-dependent kinase inhibitor 2A, isoform 1; cyclin-dependent kinase inhibitor 2A, isoform 2; cyclin-dependent kinase inhibitor 2A, isoform 3; cyclin-dependent kinase inhibitor 2A, isoforms 1/2; cyclin-dependent kinase inhibitor protein; EMBL:AAL76336.1, ECO:0000312; EMBL:AAL76338.1, ECO:0000312; HGNC:1787; inhibits CDK4; INK4; INK4A; Ink4a/Arf; INK4a-ARF; isoforms 1/2/3; Melanoma p16 inhibits CDK4; mitochondrial smARF; MLM; MTS1; MTS-1; Multiple tumor suppressor 1; P14; P14 P16; P14ARF; p16; p16(INK4a); p16Cdkn2a; P16INK4; p16-INK4; p16INK4a; p16-INK4a; P19; P19 TP16; p19<ARF>; P19ARF; Pctr1; RGD:2323}; TP16; Tumor suppressor ARF
Immunogen: Recombinant fragment (around aa1-100) of human CDKN2A protein (exact sequence is proprietary)
Primary or Secondary: Primary
Content And Storage: 4° C
Gene: CDKN2A
Clone: rCDKN2A/8062
Applications: Immunohistochemistry (Paraffin)
Conjugate: Unconjugated
Host Species: Mouse
Target Species: Human
Gene Accession No.: P42771
Gene ID (Entrez): 1029
Isotype: IgG1 κ
Purification Method: Protein A/G
Product Type: Antibody
Antigen:
P16INK4a
Concentration:
200 μg/mL
Classification:
Recombinant Monoclonal
Form:
Liquid
Regulatory Status:
RUO
Formulation:
PBS with 0.5% BSA and 0.5% sodium azide
Gene Alias:
Alternative reading frame; Arf; ARF-INK4a; CDK4 inhibitor p16 INK4; CDK4 inhibitor p16-INK4; CDK4I; CDKN2; Cdkn2a; cdkn2a {ECO:0000312; cell cycle inhibitor; cell cycle negative regulator beta; cell cycle regulator; CMM2; Cyclin dependent kinase 4 inhibitor A; cyclin dependent kinase inhibitor 2A; Cyclin dependent kinase inhibitor 2A (p16, inhibits CDK4); cyclin-dependent kinase 4 inhibitor A; Cyclin-dependent kinase inhibitor 2A; cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4); cyclin-dependent kinase inhibitor 2A (p16, inhibits CDK4); cyclin-dependent kinase inhibitor 2a p16Ink4a; cyclin-dependent kinase inhibitor 2a p19Arf; cyclin-dependent kinase inhibitor 2A, isoform 1; cyclin-dependent kinase inhibitor 2A, isoform 2; cyclin-dependent kinase inhibitor 2A, isoform 3; cyclin-dependent kinase inhibitor 2A, isoforms 1/2; cyclin-dependent kinase inhibitor protein; EMBL:AAL76336.1, ECO:0000312; EMBL:AAL76338.1, ECO:0000312; HGNC:1787; inhibits CDK4; INK4; INK4A; Ink4a/Arf; INK4a-ARF; isoforms 1/2/3; Melanoma p16 inhibits CDK4; mitochondrial smARF; MLM; MTS1; MTS-1; Multiple tumor suppressor 1; P14; P14 P16; P14ARF; p16; p16(INK4a); p16Cdkn2a; P16INK4; p16-INK4; p16INK4a; p16-INK4a; P19; P19 TP16; p19<ARF>; P19ARF; Pctr1; RGD:2323}; TP16; Tumor suppressor ARF
Immunogen:
Recombinant fragment (around aa1-100) of human CDKN2A protein (exact sequence is proprietary)
Primary or Secondary:
Primary
Content And Storage:
4° C
Gene:
CDKN2A
Clone:
rCDKN2A/8062
Applications:
Immunohistochemistry (Paraffin)
Conjugate:
Unconjugated
Host Species:
Mouse
Target Species:
Human
Gene Accession No.:
P42771
Gene ID (Entrez):
1029
Isotype:
IgG1 κ
Purification Method:
Protein A/G
Product Type:
Antibody
Antigen: S100A11 (S100 calcium binding protein A11)/Calgizzarin
Concentration: 200 μg/mL
Classification: Monoclonal
Form: Liquid
Regulatory Status: RUO
Formulation: PBS with 0.5% BSA and 0.5% sodium azide
Gene Alias: cal; Calgizzarin; calizzarin; EMAP; Emap1; EMAPI; endothelial monocyte activating polypeptide 1; endothelial monocyte-activating polypeptide; epididymis secretory protein Li 43; HEL-S-43; Metastatic lymph node gene 70 protein; MLN 70; MLN70; Protein S100-A11; Protein S100-A11, N-terminally processed; Protein S100C; Protein S100-C; S100 calcium binding protein A11; S100 calcium binding protein A11 (calgizzarin); S100 calcium binding protein A11 (calizzarin); S100 calcium binding protein A14; S100 calcium-binding protein A11; S100 calcium-binding protein A11 (calgizzarin); S100a11; S100a14; S100C
Immunogen: Recombinant full-length human S100A11 protein
Primary or Secondary: Primary
Content And Storage: 4° C
Gene: S100A11
Clone: S100A11/7394
Applications: Immunohistochemistry (Paraffin)
Conjugate: Unconjugated
Host Species: Mouse
Target Species: Human
Gene Accession No.: P31949
Gene ID (Entrez): 6282
Isotype: IgG1 κ
Purification Method: Protein A/G
Product Type: Antibody
Antigen:
S100A11 (S100 calcium binding protein A11)/Calgizzarin
Concentration:
200 μg/mL
Classification:
Monoclonal
Form:
Liquid
Regulatory Status:
RUO
Formulation:
PBS with 0.5% BSA and 0.5% sodium azide
Gene Alias:
cal; Calgizzarin; calizzarin; EMAP; Emap1; EMAPI; endothelial monocyte activating polypeptide 1; endothelial monocyte-activating polypeptide; epididymis secretory protein Li 43; HEL-S-43; Metastatic lymph node gene 70 protein; MLN 70; MLN70; Protein S100-A11; Protein S100-A11, N-terminally processed; Protein S100C; Protein S100-C; S100 calcium binding protein A11; S100 calcium binding protein A11 (calgizzarin); S100 calcium binding protein A11 (calizzarin); S100 calcium binding protein A14; S100 calcium-binding protein A11; S100 calcium-binding protein A11 (calgizzarin); S100a11; S100a14; S100C
Immunogen:
Recombinant full-length human S100A11 protein
Primary or Secondary:
Primary
Content And Storage:
4° C
Gene:
S100A11
Clone:
S100A11/7394
Applications:
Immunohistochemistry (Paraffin)
Conjugate:
Unconjugated
Host Species:
Mouse
Target Species:
Human
Gene Accession No.:
P31949
Gene ID (Entrez):
6282
Isotype:
IgG1 κ
Purification Method:
Protein A/G
Product Type:
Antibody
Antigen: P16INK4a
Concentration: 200 μg/mL
Classification: Recombinant Monoclonal
Form: Liquid
Regulatory Status: RUO
Formulation: PBS with 0.5% BSA and 0.5% sodium azide
Gene Alias: Alternative reading frame; Arf; ARF-INK4a; CDK4 inhibitor p16 INK4; CDK4 inhibitor p16-INK4; CDK4I; CDKN2; Cdkn2a; cdkn2a {ECO:0000312; cell cycle inhibitor; cell cycle negative regulator beta; cell cycle regulator; CMM2; Cyclin dependent kinase 4 inhibitor A; cyclin dependent kinase inhibitor 2A; Cyclin dependent kinase inhibitor 2A (p16, inhibits CDK4); cyclin-dependent kinase 4 inhibitor A; Cyclin-dependent kinase inhibitor 2A; cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4); cyclin-dependent kinase inhibitor 2A (p16, inhibits CDK4); cyclin-dependent kinase inhibitor 2a p16Ink4a; cyclin-dependent kinase inhibitor 2a p19Arf; cyclin-dependent kinase inhibitor 2A, isoform 1; cyclin-dependent kinase inhibitor 2A, isoform 2; cyclin-dependent kinase inhibitor 2A, isoform 3; cyclin-dependent kinase inhibitor 2A, isoforms 1/2; cyclin-dependent kinase inhibitor protein; EMBL:AAL76336.1, ECO:0000312; EMBL:AAL76338.1, ECO:0000312; HGNC:1787; inhibits CDK4; INK4; INK4A; Ink4a/Arf; INK4a-ARF; isoforms 1/2/3; Melanoma p16 inhibits CDK4; mitochondrial smARF; MLM; MTS1; MTS-1; Multiple tumor suppressor 1; P14; P14 P16; P14ARF; p16; p16(INK4a); p16Cdkn2a; P16INK4; p16-INK4; p16INK4a; p16-INK4a; P19; P19 TP16; p19<ARF>; P19ARF; Pctr1; RGD:2323}; TP16; Tumor suppressor ARF
Immunogen: Recombinant fragment (around aa1-100) of human CDKN2A protein (exact sequence is proprietary)
Primary or Secondary: Primary
Content And Storage: 4° C
Gene: CDKN2A
Clone: rCDKN2A/8061
Applications: Immunohistochemistry (Paraffin)
Conjugate: Unconjugated
Host Species: Mouse
Target Species: Human
Gene Accession No.: P42771
Gene ID (Entrez): 1029
Isotype: IgG1 κ
Purification Method: Protein A/G
Product Type: Antibody
Antigen:
P16INK4a
Concentration:
200 μg/mL
Classification:
Recombinant Monoclonal
Form:
Liquid
Regulatory Status:
RUO
Formulation:
PBS with 0.5% BSA and 0.5% sodium azide
Gene Alias:
Alternative reading frame; Arf; ARF-INK4a; CDK4 inhibitor p16 INK4; CDK4 inhibitor p16-INK4; CDK4I; CDKN2; Cdkn2a; cdkn2a {ECO:0000312; cell cycle inhibitor; cell cycle negative regulator beta; cell cycle regulator; CMM2; Cyclin dependent kinase 4 inhibitor A; cyclin dependent kinase inhibitor 2A; Cyclin dependent kinase inhibitor 2A (p16, inhibits CDK4); cyclin-dependent kinase 4 inhibitor A; Cyclin-dependent kinase inhibitor 2A; cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4); cyclin-dependent kinase inhibitor 2A (p16, inhibits CDK4); cyclin-dependent kinase inhibitor 2a p16Ink4a; cyclin-dependent kinase inhibitor 2a p19Arf; cyclin-dependent kinase inhibitor 2A, isoform 1; cyclin-dependent kinase inhibitor 2A, isoform 2; cyclin-dependent kinase inhibitor 2A, isoform 3; cyclin-dependent kinase inhibitor 2A, isoforms 1/2; cyclin-dependent kinase inhibitor protein; EMBL:AAL76336.1, ECO:0000312; EMBL:AAL76338.1, ECO:0000312; HGNC:1787; inhibits CDK4; INK4; INK4A; Ink4a/Arf; INK4a-ARF; isoforms 1/2/3; Melanoma p16 inhibits CDK4; mitochondrial smARF; MLM; MTS1; MTS-1; Multiple tumor suppressor 1; P14; P14 P16; P14ARF; p16; p16(INK4a); p16Cdkn2a; P16INK4; p16-INK4; p16INK4a; p16-INK4a; P19; P19 TP16; p19<ARF>; P19ARF; Pctr1; RGD:2323}; TP16; Tumor suppressor ARF
Immunogen:
Recombinant fragment (around aa1-100) of human CDKN2A protein (exact sequence is proprietary)
Primary or Secondary:
Primary
Content And Storage:
4° C
Gene:
CDKN2A
Clone:
rCDKN2A/8061
Applications:
Immunohistochemistry (Paraffin)
Conjugate:
Unconjugated
Host Species:
Mouse
Target Species:
Human
Gene Accession No.:
P42771
Gene ID (Entrez):
1029
Isotype:
IgG1 κ
Purification Method:
Protein A/G
Product Type:
Antibody